Literature DB >> 10921988

Lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds, and presumed acute community-acquired bacterial sinusitis.

M D Niehaus1, J M Gwaltney, J O Hendley, M J Newman, P W Heymann, G P Rakes, T A Platts-Mills, R L Guerrant.   

Abstract

To distinguish sinusitis from uncomplicated "colds," we examined lactoferrin and eosinophilic cationic protein (ECP) in nasal secretions. Lactoferrin titers were >/=1:400 in 4% of persons with uncomplicated colds and controls but in 79% of persons with sinusitis or purulent sputa. ECP levels were >200 ng/ml in 61% of persons with colds and >3,000 ng/ml in 62% of persons with sinusitis. Nasal lactoferrin helps distinguish sinusitis from colds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921988      PMCID: PMC87198     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Chronic sinusitis: risk factors for extensive disease.

Authors:  G E Hoover; L J Newman; T A Platts-Mills; C D Phillips; C W Gross; L M Wheatley
Journal:  J Allergy Clin Immunol       Date:  1997-08       Impact factor: 10.793

Review 2.  Acute community-acquired sinusitis.

Authors:  J M Gwaltney
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

3.  Measurement of fecal lactoferrin as a marker of fecal leukocytes.

Authors:  R L Guerrant; V Araujo; E Soares; K Kotloff; A A Lima; W H Cooper; A G Lee
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  Human nasal polyp epithelial basophil/mast cell and eosinophil colony-stimulating activity. The effect is T-cell-dependent.

Authors:  M Ohnishi; J Ruhno; J Bienenstock; R Milner; J Dolovich; J A Denburg
Journal:  Am Rev Respir Dis       Date:  1988-09

5.  Occurrence of asymptomatic sinusitis in common cold and other acute ENT-infections.

Authors:  O Berg; C Carenfelt; G Rystedt; A Anggård
Journal:  Rhinology       Date:  1986-09       Impact factor: 3.681

6.  Computed tomographic study of the common cold.

Authors:  J M Gwaltney; C D Phillips; R D Miller; D K Riker
Journal:  N Engl J Med       Date:  1994-01-06       Impact factor: 91.245

7.  Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease.

Authors:  W H Yong; A R Mattia; M J Ferraro
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia.

Authors:  L J Newman; T A Platts-Mills; C D Phillips; K C Hazen; C W Gross
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

9.  Eosinophil cationic protein in serum and nasal washes from wheezing infants and children.

Authors:  J M Ingram; G P Rakes; G E Hoover; T A Platts-Mills; P W Heymann
Journal:  J Pediatr       Date:  1995-10       Impact factor: 4.406

10.  Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis.

Authors:  D L Hamilos; D Y Leung; R Wood; L Cunningham; D K Bean; Z Yasruel; E Schotman; Q Hamid
Journal:  J Allergy Clin Immunol       Date:  1995-10       Impact factor: 10.793

View more
  4 in total

1.  Collection of nasal secretions for immunological analysis.

Authors:  Jean-Baptiste Watelet; Philippe Gevaert; Gabriele Holtappels; Paul Van Cauwenberge; Claus Bachert
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-09       Impact factor: 2.503

Review 2.  Analysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte.

Authors:  Jonas Bystrom; Kawa Amin; David Bishop-Bailey
Journal:  Respir Res       Date:  2011-01-14

3.  Infection, eosinophilia and childhood asthma.

Authors:  Chang-Keun Kim; Zak Callaway; Takao Fujisawa
Journal:  Asia Pac Allergy       Date:  2012-01-31

Review 4.  Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal:  Pulm Pharmacol Ther       Date:  2014-11-13       Impact factor: 3.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.